{"id":338,"date":"2023-09-01T14:31:53","date_gmt":"2023-09-01T14:31:53","guid":{"rendered":"https:\/\/www.americanconference.com\/otc-drugs\/?page_id=338"},"modified":"2024-01-05T20:28:29","modified_gmt":"2024-01-05T20:28:29","slug":"overview","status":"publish","type":"page","link":"https:\/\/www.americanconference.com\/otc-drugs\/","title":{"rendered":"Overview"},"content":{"rendered":"
\r\n
\r\n

ACI\u2019s Advanced Legal, Regulatory, and Compliance Forum on Over-the-Counter Drugs will return this January to help you navigate the ever evolving legal and regulatory landscape of the non-prescription drug industry.<\/strong><\/h4>\r\n <\/div>\r\n<\/div>\r\n\r\n
\r\n
\r\n
\r\n\r\n
\r\n
\r\n
FDA Insights<\/span><\/span><\/h6>\r\n <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\r\n \"Speaker\"\r\n

Dan Brum<\/strong><\/h4>\r\n

PharmD, MBA, BCPS, Chief of Project Management, Office of Nonprescription Drugs<\/em>
Food and Drug Administration (FDA)<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n
\r\n
Co-Chairs<\/span><\/span><\/h6>\r\n <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\r\n \"Speaker\"\r\n

Liping Wu, MD, PhD, RAC<\/strong><\/h4>\r\n

Global Regulatory Affairs Manager<\/em>
Kenvue<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n

\r\n
\r\n \"Speaker\"\r\n

Heidi Gertner<\/strong><\/h4>\r\n

Partner<\/em>
Hogan Lovells US LLP<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n
\r\n
Gain Insights from Key Industry Leaders<\/span><\/span><\/h6>\r\n <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\r\n \"Speaker\"\r\n

Meghan G. Walters Price<\/strong><\/h4>\r\n

Director and Assistant General Counsel<\/em>
The Procter & Gamble Company<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n

\r\n
\r\n \"Speaker\"\r\n

Todd Halpern<\/strong><\/h4>\r\n

Assistant General Counsel<\/em>
Haleon<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n

\r\n
\r\n \"Speaker\"\r\n

Amy Replogle<\/strong><\/h4>\r\n

Director, Rx-to-OTC Switch<\/em>
Bayer<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n

\r\n
\r\n \"Speaker\"\r\n

Ludjane Carvalho<\/strong><\/h4>\r\n

Director Regulatory Affairs<\/em>
Colgate-Palmolive<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n

\r\n
\r\n \"Speaker\"\r\n

Liping Wu<\/strong><\/h4>\r\n

MD, PhD, RAC, Global Regulatory Affairs Manager<\/em>
Kenvue<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n
\r\n
NAD Insights<\/span><\/span><\/h6>\r\n <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\r\n \"Speaker\"\r\n

Jennifer Santos<\/strong><\/h4>\r\n

Attorney<\/em>
National Advertising Division (NAD)<\/strong><\/p>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n
\r\n

This unique forum, designed for in-house counsel and executives, as well as private practice attorneys working for the OTC drug industry will provide invaluable insights on FDA’s most recent directives and compliance standards governing OTC drug production, marketing, and distribution.<\/p>\r\n \r\n

Featured sessions, include:<\/strong><\/p>\r\n